Anticoagulants Marketplace Reviewed & Forecast in New DelveInsight Report Now Available at

20 Nov 2015 • by Natalie Aster

LONDON – A large number of anticoagulants are made used of in atrial fibrillation as well as venous thromboembolism (aka VTE).

The global VTE marketplace reached a value of more than USD 3.95 billion in 2014. This marketplace is expected to grow at a CAGR of approximately 8.3 percent in the upcoming years. It is forecast to be worth over USD 5.45 billion by 2018.

In 2014, the atrial fibrillation marketplace amounted to USD 7.86 billion in 2014. It is set to hit the USD 13.28 billion mark in 2018, showing a 14 percent CAGR.

However, the market for anticoagulants is set to register a decline after 2018 due to the fact that a large number of anticoagulants will become generic.

New research study “Anticoagulants - Competitive Landscape, & Pipeline Insights, 2015” elaborated by DelveInsight provides an up-close look at the market for anticoagulants. The report contains a detailed overview of anticoagulants. It insightfully examines the global marketplace. The study comprises figures related to annual sales of anticoagulants as well as sales of top suppliers. VTE and atrial fibrillation annual estimates and forecast figures can be found in the research report, too. Detailed epidemiology for each region is contained and trends in epidemiology are discussed in the study. The research report comprises an in-depth pipeline analysis and assessments of strategic competitors. Market opportunities, challenges, barriers and regulatory restraints are investigated in the study, as well.

Report Details:

Anticoagulants - Competitive Landscape, & Pipeline Insights, 2015
Published: November, 2015
Price: US$ 1,750.00

More new studies by this publisher are available at DelveInsight page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970